Multiscale Modeling of an 8‐Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection
Carolin Zitzmann, Ruy M. Ribeiro, Aurelien Marc, Xiao‐Jian Zhou, Alan S. Perelson · 2026
Read Multiscale Modeling of an 8‐Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection by Carolin Zitzmann, Ruy M. Ribeiro, Aurelien Marc, Xiao‐Jian Zhou, Alan S. Perelson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13541962.txt.
Description
Carolin Zitzmann and co-authors model how two drugs clear hepatitis C over an eight-week course. Their twenty twenty-six paper studies bemnifosbuvir plus ruzasvir in two hundred fifteen patients new to treatment. The pair block two virus proteins needed for copying.
A multiscale math model was fit to virus levels and a liver enzyme over time. Virus load fell in three phases, the first within half a day. Most patients hit near-zero virus in about two weeks, with slower clearance in scarred livers. The model also marks an estimated cure point near six weeks. Such models help set the shortest course that still cures.
Catalog record
| CREATOR | Carolin Zitzmann, Ruy M. Ribeiro, Aurelien Marc, Xiao‐Jian Zhou, Alan S. Perelson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |